How funds voted at Century Therapeutics, Inc.
- Ticker
- IPSC
- SEC company number
- 1850119
- Filers reporting
- 14, year to 30 June 2026
- Latest meeting on file
- Meetings on file
- 4
In the year to 30 June 2026, 14 filers on Form N-PX reported votes at Century Therapeutics, Inc.. The votes fall in 2 meetings. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 66 marks to the ballot items, each with or against management. 100.0% of the marks are with management.
In the year to 30 June 2026, no say-on-pay item is on file for Century Therapeutics, Inc.. So there is no figure to give.
By filers reporting in the year to 30 June 2026, Century Therapeutics, Inc. was number 9,998 of 11,972 companies with a page and votes in that year. The number of filers reporting at Century Therapeutics, Inc. fell by 67.4% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category AUDIT-RELATED is 20.8% of the vote records at Century Therapeutics, Inc.. At all companies on this site, it is 6.8%.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2026. Filings read through . How the figures are made
Since the last update
The site has recorded no change in the tracked figures of this page.
Tracked: the meetings on file and the date of the latest meeting. All recorded changes
The ballot of 12 Jun 2025
43 filers reported votes at this meeting in the year to 30 June 2025. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.
Item 1: Director elections
2 nominees. 63.0% of the reported votes are for. 21 filers withheld from or voted against at least one nominee.
144 vote records from 43 filers. 14 of the 43 filers that marked the item voted against management.
- Positions of 20 fund families
- For 11
- Abstain or withhold 6
- Split or no vote 3
- Against management 6
Item 2: Audit-related items (auditor ratification)
72 vote records from 43 filers. 0 of the 43 filers that marked the item voted against management.
- Positions of 20 fund families
- For 20
Positions of the fund families at the meeting of 12 Jun 2025
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | Auditor |
|---|---|
| BlackRock and iShares | For |
| Charles Schwab | For |
| DWS | For |
| Equitable | For |
| Fidelity | For |
| Global X | For |
| Goldman Sachs | For |
| Guggenheim and Rydex | For |
| Lincoln Financial | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| Nationwide | For |
| Northern Trust and FlexShares | For |
| Nuveen and TIAA | For |
| Pacific Life funds | For |
| ProShares and ProFunds | For |
| SEI | For |
| State Street and SPDR | For |
| T. Rowe Price | For |
| Vanguard | For |
| Victory Capital | For |
Every meeting on file
Say-on-pay, season by season
| Season | Filers reporting | Filers against management | Reported shares against management | |
|---|---|---|---|---|
| year to 30 June 2026 | 14 | not reported | not reported | |
| year to 30 June 2025 | 43 | not reported | not reported | |
| year to 30 June 2024 | 54 | not reported | not reported |
| Say-on-pay | This company | Median of companies on this site |
|---|---|---|
| Filers against management | not reported | 6.6% |
| Reported shares against management | not reported | 2.9% |
The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.
| Category | Vote records | Share |
|---|---|---|
| DIRECTOR ELECTIONS | 465 | 51.7% |
| AUDIT-RELATED | 187 | 20.8% |
| CAPITAL STRUCTURE | 33 | 3.7% |
| CORPORATE GOVERNANCE | 215 | 23.9% |
The record at the SEC
- SEC: Mutual Fund Proxy Voting Records and PoliciesThe SEC page on where to find the proxy voting record of a fund.
- SEC: Form N-PX and its instructions (PDF)The form that funds and managers file, with its instructions and the vote categories.
- SEC: final rule on enhanced reporting of proxy votesThe 2022 rule that set the present form and the say-on-pay report of managers.
- EDGAR full text search, Form N-PXThe SEC search of filing text, set to Form N-PX.
Each link loaded on .
Cite this page
Vote Scores. How funds voted at Century Therapeutics, Inc.. https://votescores.com/company/century-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .
Questions
- How many meetings of Century Therapeutics, Inc. are on file?
- 4 meetings are on file, from 20 Jun 2024 to 11 Jun 2026. 2 meetings have 20 or more reporting filers and have their own page.
- Did filers report proposals from security holders at Century Therapeutics, Inc.?
- Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
- Is this the meeting result?
- No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Century Therapeutics, Inc. reports the result of a vote on Form 8-K.
- How does the site group meetings and names?
- Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Century Therapeutics, Inc., grouped by company. The name is the most common spelling among filers. The ticker and the SEC company number come from the SEC company tickers file, matched on the exact name. The filers wrote the filings. Filings read through .